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Abstract  32 
Evolutionary differences in gene regulation between humans and lower mammalian experimental 33 
systems are incompletely understood, a potential translational obstacle that is challenging to 34 
surmount in neurons, where primary tissue availability is poor. Rodent-based studies show that 35 
activity-dependent transcriptional programs mediate myriad functions in neuronal development, but 36 
the extent of their conservation in human neurons is unknown. We compared activity-dependent 37 
transcriptional responses in developing human stem cell-derived cortical neurons with those 38 
induced in developing primary- or stem cell-derived mouse cortical neurons. While activity-39 
dependent gene-responsiveness showed little dependence on developmental stage or origin 40 
(primary tissue vs. stem cell), notable species-dependent differences were observed. Moreover, 41 
differential species-specific gene ortholog regulation was recapitulated in aneuploid mouse 42 
neurons carrying human chromosome-21, implicating promoter/enhancer sequence divergence as 43 
a factor, including human-specific activity-responsive AP-1 sites. These findings support the use of 44 
human neuronal systems for probing transcriptional responses to physiological stimuli or indeed 45 
pharmaceutical agents. 46 
 47 
 48 
 49 
Introduction 50 
The last common ancestor of mice and humans existed around 80 million years ago, sufficient time 51 
for divergence in signal-dependent gene regulation 1. However, the conservation or divergence of 52 
dynamic signal-dependent programs of gene expression is incompletely understood, particularly in 53 
the nervous system. A fundamental transcriptional program of this sort is that elicited in neurons by 54 
electrical activity, triggered via Ca2+ influx through ligand- and/or voltage-gated Ca2+ channels and 55 
activating genes containing Ca2+-responsive transcription factor binding sites in their promoters 2-4. 56 
These changes in gene expression are critical to a neuron’s functional response to electrical 57 
activity in development and maturity 5-7, and are totally distinct from the toxic sequelae of 58 
excitotoxic Ca2+ influx 8, 9. For example, rodent studies have shown that activity-dependent gene 59 
expression programs direct myriad processes in developing neurons, including neuroprotection, 60 
dendritic arborization, and synaptic plasticity 5-7. Moreover, certain neurodevelopmental disorders 61 
are associated with defects in activity-dependent transcriptional mechanisms 6, making it important 62 
to fully understand transcriptional programs that are triggered by electrical activity in developing 63 
human neurons. 64 
 Comparing the influence of neuronal electrical activity on mouse-human orthologs, and 65 
identifying the basis for any differences, requires a combination of approaches, given the inability 66 
to reproducibly study primary human developing neurons. Embryonic stem cell (ESC)-based 67 
technology enables the generation of glutamatergic cortical-patterned neurons from human 68 
embryonic stem cells (hESCCORT-neurons) of sufficient homogeneity and electrical maturity 10, 11 to 69 
enable the study of activity-dependent gene expression. Such responses can then be compared to 70 
both primary mouse cortical neurons (of differing developmental stages) as well as those derived 71 
from mouse ESCs, to distinguish species-specific differences from those dependent on 72 
developmental stage or origin (primary tissue vs. stem cell line). Moreover, it is in theory possible 73 
to study mouse-human ortholog regulation in the same neuron by exploiting the aneuploid Tc1 74 
mouse which carries a freely segregating copy of human Chromosome 21, to identify whether any 75 
differences are independent of cellular environment (i.e. are due to DNA sequence divergence). A 76 
combination of these approaches has been employed to reveal strong conservation of the 77 
neuronal activity-dependent transcriptome onto which a significant degree of divergence is overlaid. 78 
 79 
 80 
Results and Discussion 81 
We generated dissociated glutamatergic cortical-patterned neurons from human embryonic stem 82 
cells (hESCCORT-neurons), whose characterisation is described fully elsewhere 10, 11. These cells 83 
have a combination of homogeneity and electrical maturity that is hard to achieve with classical 84 
human stem cell-derived neurosphere-based preparations, which have a poor dynamic range in 85 
terms of gene regulation 12 compared to primary mouse neuronal preparations 13 86 
 We studied transcriptional responses to L-type Ca2+ channel activation, an important 87 
mediator of activity-dependent gene regulation 6, 14-18. To do this, hESCCORT-neurons were subject 88 
to KCl-induced membrane depolarization in the presence of the L-type Ca2+ channel agonist 89 
FPL64176 (KCl/FPL), which leads to robust and uniform Ca2+ responses (10, Figure 1-figure 90 
supplement 1a, Figure_1_Source_Data_2) similar to rodent neurons 19. QPCR analysis revealed 91 
robust induction of classical early-response activity-regulated genes (ARGs) FOS, FOSL2 (FRA-2), 92 
and FOSB, and neurobiologically important ARGs BDNF, ARC, and NPAS4 (Figure 1-figure 93 
supplement 1b, Figure_1_Source_Data_3) whose regulation has hitherto been studied primarily in 94 
rodent neurons.  95 
 We then performed RNA-seq analysis of KCl/FPL-induced gene expression changes in 96 
hESCCORT-neurons as well as days-in-vitro (DIV)10 mouse primary cortical neurons (Mus-97 
PRIMCORT-neurons, predominantly excitatory, like Hum-ESCCORT-neurons), focusing on a 4h 98 
timepoint (Fig. 1a,b, Figure_1_Source_Data_1). QPCR validation of fold-induction of selected 99 
ARGs revealed a tight correlation with the RNA-seq data (r >0.99 for Hum-ESCCORT-neurons and 100 
mouse neurons respectively, Figure 1-figure supplement 1c, 1d, Figure_1_Source_Data_4), 101 
supporting the reliability of the RNA-seq data set. Our interspecies comparisons were restricted to 102 
1:1 orthologous pairs whose average expression level met a minimum threshold (11,302 genes 103 
expressed >0.5 FPKM on average, in all cell types). Genes induced >5-fold in both Hum-ESCCORT- 104 
and DIV10 Mus-PRIMCORT-neurons according to RNA-seq included neurobiologically important 105 
genes such as PER1, EGR2, EGR4 and ATF3 (Fig. 1c). Global comparison of Log2 (gene fold-106 
change) in orthologous pairs revealed a correlation between Hum-ESCCORT-neurons and DIV10 107 
Mus-PRIMCORT-neurons (r=0.480, 95% CI: 0.465 to 0.494, P<0.0001, Fig. 1d, 108 
Figure_1_Source_Data_1), pointing to a significant, but incomplete, degree of conservation. For 109 
the 11,302 ortholog pairs, we calculated the "differential regulation index" (DRI), defined as the 110 
fold-change (Hum-ESCCORT-neurons) divided by the fold-change (Mus-PRIMCORT-neurons). The 111 
log2 of the DRIs are normally distributed about zero with a standard deviation of 0.68 (Figure 1-112 
figure supplement 1e, Figure_1_Source_Data_5). 113 
 While this imperfect conservation could involve species-specific gene responsiveness, it 114 
could be due to other factors: i) non-developmental equivalency in the human and mouse neuronal 115 
preparations combined with a dependency of the responsiveness of certain genes on 116 
developmental stage could underlie differences; ii) if gene-responsiveness were sensitive to the 117 
origin of the neurons studied (embryonic stem cell line (human) vs. primary tissue (mouse)) this 118 
could also lead to differences, and an erroneous exaggeration of apparent evolutionary divergence. 119 
To address (i) we compared KCl/FPL-induced gene regulation in DIV10 Mus-PRIMCORT-neurons 120 
with that in synaptically immature DIV4 Mus-PRIMCORT-neurons, which revealed a strong 121 
correlation (P<0.0001, r=0.834, 95% CI: 0.833 to 0.844, Fig. 1e, Figure_1_Source_Data_1), and a 122 
log2 DRI (DIV4:DIV10) distribution curve (Figure 1-figure supplement 1f, Figure_1_Source_Data_5) 123 
substantially narrower than that observed in Figure 1-figure supplement 1e. Taken together, this 124 
suggests that developmental stage does not have a large effect on the activity-responsiveness of 125 
genes at this time point and is unlikely to account for the human-mouse differences observed in 126 
Fig. 1d. 127 
 To address (ii) (i.e. whether stem cell- vs. primary tissue origin causes differential gene 128 
responsiveness) we generated cortical-patterned neurons from mouse embryonic stem cells (Mus-129 
ESCCORT-neurons) using established protocols 20, which exhibit spontaneous firing and synaptic 130 
activity (Fig. 2a-d), similar to our Hum-ESCCORT-neurons 10, 11. The Mus-ESCCORT-neurons were 131 
subject to the same 4h KCl/FPL stimulation and RNA-seq analysis (Figure 2-figure supplement 1a). 132 
Same-species comparison of gene fold-change was made between Mus-PRIMCORT-neurons (DIV4 133 
and DIV10) and Mus-ESCCORT-neurons in the 11,302 genes compared in Fig. 1e,f. A strong 134 
correlation was observed in gene-responsiveness in Mus-ESCCORT-neurons vs. Mus-PRIMCORT-135 
neurons at either DIV10 or DIV4 (P<0.0001, r=0.748 (DIV10), Fig. 2e; r=0.788, (DIV4), Fig. 2f), 136 
significantly stronger than between Mus-ESCCORT- and Hum-ESCCORT-neurons (r=0.596, Fig. 2g, 137 
see also Figure_2_Source_Data_1). Indeed, a comparison of gene fold-change between all 138 
biological replicates in all data sets revealed that all mouse neuronal preparations (primary DIV10, 139 
primary DIV4, and ESC-derived) correlated far more strongly with each other than with the human 140 
ESCCORT-neurons. (Fig. 2h). This suggests that the weaker correlation with the hESCCORT-neurons 141 
may indeed be due to some species-specific differences in neuronal gene activity-responsiveness, 142 
rather than differences in developmental stage or cellular origin.  143 
 As a final genome-wide comparison we wanted to determine whether activity-dependent 144 
gene responsiveness showed a higher or lower degree of divergence than basal gene expression 145 
levels, and whether differences in basal gene expression were any predictor of differential activity-146 
dependent gene responsiveness. Comparison of basal expression levels between Hum-ESCCORT-147 
neurons and mouse neurons (DIV10 Mus-PRIMCORT-neurons, DIV4 Mus-PRIMCORT-neurons, and 148 
Mus-ESCCORT-neurons) revealed correlation coefficients of 0.714, 0.711, and 0.710 (Figure 2-figure 149 
supplement 1b-d, Figure_2_Source_Data_3). This correlation is substantially stronger than the that 150 
observed when comparing gene fold-change after KCl stimulation (0.480, 0.526, .595, Fig. 1d, 2g, 151 
Figure 1-figure supplement 1g). Moreover, we performed a similar clustering analysis as in Fig. 2h 152 
which illustrates this graphically: i.e. while the basal expression profile of Hum-ESCCORT-neurons 153 
does not cluster as closely as the three mouse neuronal populations do to each other, the degree 154 
of difference is less than that observed in Fig. 2h (Fig. 2i). Therefore basal neuronal gene 155 
expression shows less divergence than the responsiveness of genes to depolarisation. We also 156 
investigated whether gene differential responsiveness to KCl (DRI) in human vs. mouse neurons 157 
has any relationship with the relative basal expression of that gene in human vs. mouse neurons. 158 
For each of the 11,302 orthologous pairs, we plotted the Log2(DRI) Hum-ESCCORT- vs. DIV10 Mus-159 
PRIMCORT-neurons (i.e. DRIs from Figure 1-figure supplement 1e) against the Log2(DBEI), where 160 
DBI (differential basal expression index) is the ratio of basal expression in Hum-ESCCORT- vs. 161 
DIV10 Mus-PRIMCORT-neurons (Figure 2-figure supplement 1e, Figure_2_Source_Data_2). As can 162 
be seen, there is no link between a gene's relative responsiveness to depolarisation in human vs. 163 
mouse neurons, and its relative basal expression levels in human vs. mouse neurons. Moreover, if 164 
we consider the 657 genes where Log2(DRI)>1, the standard deviation of their respective 165 
Log2(DBEI), 1.45, is similar to the standard deviation of Log2(DBEI) across all 11,302 genes (1.39), 166 
suggesting that there is no dramatic change in divergence of basal gene expression regardless of 167 
direction, in genes where DRI>1. Thus, evolutionary differences in activity-dependent gene 168 
responsiveness are not substantially attributable to differences in basal expression. 169 
 We hypothesized that species-specific gene-responsiveness to neuronal activity could be in 170 
part due to evolutionary divergence in genetic sequence, such as the promoters and distal 171 
enhancers that mediate activity-dependent changes in gene expression 6, 21. To investigate 172 
whether genetic sequence could be sufficient to quantitatively influence species-specific gene 173 
inducibility, we utilized neurons cultured from the Tc1 transchromosomic mouse strain which 174 
carries a copy of human chromosome 21 (Hsa21), albeit with approximately 10% deleted 22, 23. 175 
Thus, regulation of Hsa21 genes, plus their mouse 1:1 ortholog, could be studied side-by-side in 176 
the same cellular environment of a mouse primary neuron. We cultured cortical neurons from Tc1 177 
embryos to DIV10, stimulated ± KCL/FPL, performed RNA-seq, and developed a workflow that 178 
distinguished between human and mouse RNA-seq reads, discarding any reads that were 179 
ambiguous. Once the initial criterion of a perfect sequence match of the RNA-seq read to either 180 
Hsa21 or the mouse genome was met, only a further 0.055% of reads were discarded due to 181 
100% sequence conservation between species. Thus, expression level of human and mouse 182 
genes carried in the Tc1 mouse can be analysed ± stimulation (Fig. 3a). We first verified that the 183 
mouse genes in Tc1 neurons responded similarly to wild-type mouse neurons of the same age 184 
(Figure 3-figure supplement 1a, Figure_3_Source_Data_1, r=0.900). 185 
 72 orthologous pairs were then focussed on, where the Hsa21 ortholog met an expression 186 
cut-off of >100 reads. For each pair, we calculated the "Tc1 DRI" (fold-change (human 187 
ortholog)/fold-change (mouse ortholog)) as a measure of whether responsiveness of the orthologs 188 
was different or similar, and plotted it against the gene’s DRI calculated from fold-induction in 189 
separate human/mouse neuronal preparations: fold-change (Hum-ESCCORT-neurons) / fold-change 190 
(DIV10 Mus-PRIMCORT-neurons). Importantly, we observed a significant correlation between these 191 
DRIs (P<0.0001, r=0.730, Fig. 3b, Figure_3_Source_Data_2), meaning that differences in gene 192 
regulation observed in separate human and mouse cortical neuron preparations ("separate DRI") 193 
are broadly recapitulated when the orthologs are studied side-by side in the same cellular 194 
environment ("Tc1 DRI"). This points to the DNA sequence as a contributor to quantitative species-195 
specific gene responsiveness. An example of such a gene is ETS2, the human ortholog of which is 196 
induced more strongly and rapidly than the mouse ortholog (Fig. 3c,d, Figure_3_Source_Data_3). 197 
Interestingly, a region of its proximal promoter contains three human-specific AP-1 sites (Fig. 3e, 198 
right) and was found to confer activity inducibility on a luciferase reporter, unlike the corresponding 199 
region of the mouse Ets2 promoter (Fig. 3e, left). Moreover, expression of inhibitory AP-1 mutant 200 
TAM67 24 inhibited Hum-ETS2-luciferase reporter induction, and mutation of the three AP-1 sites to 201 
the corresponding mouse sequence abolished inducibility (Fig. 3e). Thus, the ETS2 proximal 202 
promoter contains functional human-specific AP-1 sites, potentially contributing to the stronger and 203 
more rapid induction of the human ortholog in neurons 204 
 Although the focus of this study is understanding the extent and causes of differences in 205 
gene activity-responsiveness in human vs. mouse neurons, it should be noted that qualitative gene 206 
up/down regulation is well conserved. For example, of the top 100 most strongly induced human 207 
genes in Hum-ESCCORT-neurons (FC>3.5 fold, Padj<0.05), 85 are also induced in Mus-ESCCORT-208 
neurons (FC>1.5-fold, Padj<0.05). Of the remaining 15 genes, 6 are induced in DIV4 and/or DIV10 209 
Mus-PRIMCORT-neurons, taking the total to 91/100. Conserved inducibility remains high even at a 210 
lower fold-change cut-off: e.g. 409 out of 475 genes induced >2-fold (Padj<0.05) in Hum-ESCCORT-211 
neurons are also induced (FC>1.5-fold, Padj<0.05) in one or more of the mouse neuronal 212 
preparations. Although we confirmed examples of genes regulated both up and down at 4h in 213 
Hum-ESCCORT-neurons but not in mouse neurons, by performing a timecourse in Hum-ESCCORT- 214 
and DIV10-Mus-PRIMCORT neurons (Fig. 3f), we hesitate to label these as definitively human-215 
specific activity-response genes: there may be time-points, stimulation paradigms, or 216 
developmental stages that do expose activity-dependency on mouse neurons. 217 
 Nevertheless, our study points to quantitative differences in activity-dependent gene-218 
responsiveness in developing human neurons, compared to their mouse counterpart, mediated at 219 
least in part by DNA sequence divergence. It is possible that these differences have a functional 220 
impact on the physiological response of human neurons to electrical activity. More generally, given 221 
that diverse signal dependent transcriptional programs mediate cellular responses to physiological 222 
stimuli, as well as the effects (and side-effects) of pharmaceutical agents 7, 25-28, this study points to 223 
the value of employing human neurons as a tool to help bridge the translational gap between 224 
rodent studies, and human neurophysiology. 225 
 226 
 227 
Materials and Methods 228 
Generation of cortical-patterned neurons from human ES cells. A detailed description of the 229 
derivation of hESCCORT-neurons, including immunohistochemical validation of cortical markers as 230 
well as electrophysiological characterization can be found in recent studies from the authors 10, 11. 231 
Briefly, the hESC line H9 was used, and obtained from WiCell (Madison, WI) under full ethical / 232 
IRB approval of the University of Edinburgh. hESCs were maintained on CF-1 irradiated mouse 233 
embryonic fibroblasts, neurally converted to anterior-patterned neural precursor cells (NPCs) in 234 
suspension in chemically defined medium as described 29, whereupon neural rosettes were 235 
mechanically isolated, dissociated and plated for proliferative expansion. For differentiation of 236 
anterior NPCs, they were plated in default media (A-DMEM/F12, 1% P/S, 0.5% Glutamax, 0.5% 237 
N2, 0.2% B27, 2 μg/mL Heparin (Sigma)) on poly-D-lysine (Sigma), laminin (Sigma), fibronectin 238 
(Sigma) and matrigel coated coverslips for differentiation and fed twice a week. Default media was 239 
supplemented with 10 μM forskolin (Tocris) in weeks 2 and 3. From week 4 onwards forskolin was 240 
removed and default media was supplemented with 5ng/mL BDNF and 5 ng/mL GDNF. 241 
Experiments were performed 5 weeks after the differentiation of anterior NPCs was commenced.  242 
 243 
Generation of cortical-patterned neurons from mouse ES cells. Mouse ES cells (E14tg2α) were 244 
maintained in GMEM (Sigma) supplemented with 2-mercaptoethanol (Gibco), non-essential amino 245 
acids (Gibco), glutamine, pyruvate, 10% foetal calf serum (Gibco) and 100 units/ml LIF (made in-246 
house) on gelatinised tissue culture flasks Monolayer neural differentiation is described elsewhere 247 
30 and modified here to include cyclopamine. Briefly, ES cells were washed to remove all traces of 248 
serum and then plated at a density of 1x104 cells/cm2 onto gelatin-coated tissue culture plastic in 249 
N2B27 serum-free medium. N2B27 consists of a 1:1 ratio of DMEM/F12 and Neurobasal media 250 
(Gibco) supplemented with 0.5% modified N2 (made in house as described 30, 1% B27 (Gibco), 2- 251 
mercaptoethanol (Gibco), 2mM L-Glutamine, and 1uM Cyclopamine (Sigma). Medium was 252 
changed every day. Cells were cultured for 9 days under these conditions before transferring to 253 
terminal differentiation conditions. Terminal differentiation of mouse NPCs into dorsal forebrain 254 
(cortical) neurons was achieved as described elsewhere20 by withdrawal of cyclopamine from day 255 
9 NPCs dissociated into single cells, with Accutase (Life technologies), and re-plated on Matrigel 256 
(SLS, 354230; 1 in 100 dilution), Fibronectin 20mg/ml (F2006 - Sigma-Aldrich), Laminin 10 mg/ml 257 
(L2020 - Sigma-Aldrich) coated coverslips at a density of 30000 cells per 0.3cm2. Addition of 5 µM 258 
AraC on day 10, for 24h, was used to remove residual proliferating cells. Differentiating cortical 259 
neurons were maintained for a further 12-14 days, with media changes every 2-3 days, in 260 
Advanced DMEM/F12 (Invitrogen) containing: 1% N-2 supplement (Invitrogen), 1% B27 261 
supplement (Invitrogen), 1% penicillin/streptomycin (Invitrogen), 0.5% GlutaMAX (Invitrogen), and 262 
5 mg/ml heparin (Sigma), supplemented with 1mM N-acetyl cysteine (Sigma) and 10 ng/ml BDNF 263 
(R&D Systems) and finally processed for RNAseq and electrophysiological studies. For cell culture 264 
IHC, cells were fixed in 4% formaldehyde for 20 min at room temperature, washed with PBS and 265 
permeabilized with the detergent NP40 (Life Technologies). Cells were subsequently incubated in 266 
primary antibodies over night at 4°C. The next day, cells were washed with PBS and incubated 267 
with the appropriate secondary antibody at room temperature for 2h. Cells were then mounted 268 
using the mounting medium Vectashield (Vector Labs).   269 
 270 
Mouse primary cortical neuronal culture from wild-type and Tc1 mice. Cortical mouse neurons 271 
were cultured from either wild-type CD1 mice or Tc1 mice described 31 at a density of between 9-272 
13 x 104 neurons per cm2 from E17.5 mice with Neurobasal growth medium supplemented with 273 
B27 (Invitrogen, Paisley, UK). Stimulations of cultured neurons were done after a culturing period 274 
of 9-11 days during which neurons develop a network of processes, express functional NMDA-type 275 
and AMPA/kainate-type glutamate receptors, and form synaptic contacts. For Tc1 mouse 276 
genotyping, DNA was isolated from cerebellum using Qiagen QIAamp DNA Mini Kit following 277 
manufacturer’s instructions. Genotyping reactions were performed using the following primers: 278 
D21S55 Forward =5’-GGT TTG AGG GAA CAC AAA GCT TAA CTC CCA-3’, reverse =5’-ACA 279 
GAG CTA CAG CCT CTG ACA CTA TGA ACT-3’; Myo Forward =5’-TTA CGT CCA TCG TGG 280 
TGG ACA GCAT-3’, reverse =5’- TGG GCT GGG TGT TAG TCT TAT-3’. D21S55 recognizes the 281 
Tc1 allele (product =208 bp) whereas Myo recognizes both Tc1 and WT alleles (product =245 bp).  282 
 283 
Stimulation of mouse cortical and hESCCORT-neurons. Prior to stimulation, neurons were first 284 
placed overnight into a minimal defined medium 32 containing 10% MEM (Invitrogen), 90% Salt-285 
Glucose-Glycine (SGG) medium (33; SGG: 114 mM NaCl, 0.219 % NaHCO3, 5.292 mM KCl, 1 mM 286 
MgCl2, 2 mM CaCl2, 10 mM HEPES, 1 mM Glycine, 30 mM Glucose, 0.5 mM sodium pyruvate, 287 
0.1 % Phenol Red; osmolarity 325 mosm/l,32). KCl/FPL stimulations were performed as described 288 
previously 19, 34. KCl/FPL stimulation involved neurons being exposed to 50 mM KCl by adding 0.41 289 
volumes of KCl depolarization solution 33 (10 mM HEPES, pH 7.2, 170 mM KCl, 1 mM MgCl2, 2 290 
mM CaCl2) in the presence of 5 µM FPL64176 (Tocris), plus an NMDA receptor antagonist (MK-291 
801, 5 µM) to prevent any excitotoxicity. As described recently 10, hESCCORT-neurons respond 292 
strongly and uniformly to KCl/FPL treatment, with over 80% of hESCCORT-neurons exhibiting a >10-293 
fold increase in [Ca2+], and the remainder showing at least a 5-fold increase. 294 
 295 
Calcium imaging. Ca2+ imaging was performed as described 34, 35 at 37ºC in aCSF (150 mM NaCl, 296 
3 mM KCl, 10 mM HEPES, 2 mM CaCl2, 1mM MgCl2, 1mM glucose). Briefly, cells were loaded 297 
with 11µM Fluo-3 AM (from a stock solution of 2.2 mM Fluo-3 dissolved in anhydrous DMSO 298 
containing 20% (w/v) Pluronic detergent) for 30 min at 37°C. Fluo-3 fluorescence images 299 
(excitation 472 ± 15 nm, emission 520 ± 15 nm) were taken at one frame per 5 sec using a Leica 300 
AF6000 LX imaging system, with a DFC350 FX digital camera. To calibrate images, Fluo-3 was 301 
saturated by adding 50 μM ionomycin to the perfusion chamber (to obtain Fmax) and quenched with 302 
10 mM MnCl2 + 50 μM ionomycin to levels corresponding to 100 nM Ca2+ 36, which was in turn 303 
used to calculate Fmin. Free Ca2+ concentrations were calculated from fluorescence signal (F) 304 
according to the equation [Ca2+] = Kd(F – Fmin)/(Fmax – F), and expressed as a multiple of the Kd of 305 
Fluo-3 (which is approximately 315 nM).  306 
 307 
Electrophysiology. The whole-cell patch configuration was used to record membrane currents and 308 
voltage deflections as previously described 10, 37.Membrane potential data are corrected for liquid 309 
junction potential (+14 mV). Current and voltage measurements were typically low-pass filtered 310 
online at 2 kHz, digitized at 10 kHz and recorded to computer using the WinEDR V2 7.6 311 
Electrophysiology Data Recorder (J. Dempster, Department of Physiology and Pharmacology, 312 
University of Strathclyde, UK) 313 
 314 
RNA sequencing. Neurons were treated with KCl/FPL as described above. Cells were lysed and 315 
RNA extracted at 4h post-stimulation. For both mouse and human-based experiments, three 316 
independent biological replicates were performed, and analysed in parallel. Three replicates were 317 
deemed sufficient based on previous transcriptome studies on activity-dependent gene expression 318 
in which we successfully identified differentially regulated genes with this number of replicates 38. 319 
Total RNA was assessed for quality (Agilent Bionalyzer) and quantity (Invitrogen Qubit) before 320 
library preparation. Illumina libraries were prepared from 1 µg of total RNA using TruSeq RNA 321 
Sample Prep Kit v2 with a 10 cycle enrichment step as per the manufacturer's recommendations. 322 
Final libraries were pooled in equimolar proportions before Illumina sequencing on a HiSeq 2500 323 
platform using 75 base paired-end reads. Raw reads were processed using RTA 1.17.21.3 and 324 
Casava 1.8.2 (Illumina). Reads were mapped to the mouse (mm10) and human (hg38) reference 325 
genomes using version 2.4.0i of the STAR RNA-seq aligner 39. A table of per-gene read counts 326 
was generated from the mapped reads with featureCounts version 1.4.6-p2 40, using gene 327 
annotations from Ensembl version 82. Differential expression analysis was then performed using 328 
DESeq2 (R package version 1.10.0) 41. Raw data will be deposited in the European Nucleotide 329 
Archive in advance of publication. 330 
 Species-specific sorting of Tc1 neuron RNA-seq data: Given a set of RNA-seq reads that 331 
have derived from transcripts of both the mouse genome and human chromosome-21, we 332 
implemented a sorting procedure to assign reads to their true species of origin. In the balance 333 
between precision and recall, our strategy is conservative, in that it aims foremost to minimise the 334 
number of reads allocated to the incorrect species; but we simultaneously seek to maximise the 335 
number of reads that can be unambiguously assigned to the correct species. The sorting criteria 336 
detailed below were chosen to effect this goal. In this species-specific sorting (SSS) procedure, 337 
reads are first mapped to the genomes of each species with the STAR RNA-seq aligner. At this 338 
stage multi-mapping alignments are allowed (--outFilterMultimapNmax 10000), but only those with 339 
an alignment score equal to the maximum (--outFilterMultimapScoreRange 0). Subsequently, for 340 
each RNA-seq read the alignments of that read to each genome are compared. If the read has 341 
alignments to the mouse genome, but no alignments to the human chromosome-21 exist, the read 342 
is provisionally assigned to the mouse; note, however, the further requirements given below for a 343 
read to be finally allocated to this genome. Similarly, if alignments to human chromosome-21 exist, 344 
but there are no alignments to the mouse genome, the read is provisionally assigned to the human. 345 
If alignments to both genomes exist, these alignments are examined in more detail. Firstly, any 346 
read which aligns multiple times to either genome is discarded, since in this initial conservative 347 
strategy their exclusion removes a potential source of ambiguity. Next, the number of mismatched 348 
bases between the mapped read and each genome is examined. If the number of mismatches is 349 
smaller for one species, the read is provisionally allocated to that genome. If the number of 350 
mismatches for each species is equal, a further check is made on the structure of the alignments; 351 
a successful alignment is required to span the full length of the read (without any clipping of bases), 352 
and, if the alignment spans an intron, at least 5 bases are required to align to the exons on either 353 
side of the boundary. If these criteria are satisfied for the alignment to one genome, but not to the 354 
other, then the read is provisionally assigned to the first genome. If the criteria are satisfied for the 355 
alignments to both genomes, the read is rejected as ambiguous; it cannot be assigned with 356 
confidence to one species rather than the other. The read is also rejected if the structural criteria 357 
are not satisfied for the alignments to either genome. 358 
 At this stage, a read has either been provisionally allocated to one species, or has been 359 
rejected. In the former case, a final set of checks are made on the provisional alignment. In this 360 
conservative strategy, these are that there should be no mismatches between the mapped read 361 
and the genome, and that the structural criteria outlined above are satisfied (if this has not already 362 
been confirmed). The outcome of this procedure is that all reads successfully assigned to one 363 
species or the other have a single, full-length alignment to that species' genome, with no 364 
mismatched bases. Subsequently, for each sample, per-gene read counts were summarised using 365 
featureCounts. Relative expression levels of genes are expressed as fragments per million reads 366 
per kilobase of message (FPKM). Within the SSS-workflow, only reads that are unambiguously 367 
attributed to a particular species are used as the denominator in the FPKM calculation. The value 368 
for the length of message for a particular gene refers to the maximum transcript length. Where 369 
gene length data is given, this refers to the number of nucleotides contained within the union of all 370 
exons of all transcripts of the gene, including 5' and 3' UTRs. Differential expression analysis on 371 
data sets was performed using DESeq2.  372 
 373 
Plasmids and reporter assays. A region of the human ETS2 promoter (NM_001256295 -1080 to -374 
19, or NM_005239.5, positions -1622 to -542) was generated by PCR amplification using 375 
Stratagene UltraII Fusion HS DNA Polymerase kit and subcloned into pGL4.10. All other promoter 376 
sequences (both wild-type and mutant) were obtained as synthetic clones from Life Technologies 377 
(Geneart) and then subcloned into pGL4.10. This included the corresponding mouse Ets2 378 
promoter sequence (ENSMUST00000023612 -1055 to -65, or NM_011809.3 -1387 to -397) and a 379 
mutated form of the human ETS2 promoter with the putative AP-1 sites mutated to the 380 
corresponding mouse sequence (ETS2(ΔAP1)) was synthesized. The following plasmids have 381 
been described previously: pcDNA3-cJun(3-122) (TAM-67) 24. Firefly luciferase-based reporter 382 
gene constructs were transfected (Lipofectamine 2000) into DIV8 mouse cortical neurons as along 383 
with a Renilla expression vector (pTK-RL) control. The number of biological replicates were 384 
performed based on previous studies where site-directed mutagenesis was performed on reporter 385 
constructs to assess activity-dependent promoter regulation 38. Neurons were stimulated with 386 
KCl/FPL (where appropriate) 24 h after transfection. Luciferase assays were performed using the 387 
Dual Glo assay kit (Promega) with Firefly luciferase-based reporter gene activity normalized to the 388 
Renilla control (pTK-RL plasmid) in all cases. 389 
 390 
RNA extraction and qPCR. For RNA-seq and qPCR, RNA was isolated using the Roche HP RNA 391 
Isolation kit according to manufacturer’s instructions. For qPCR, cDNA was synthesized from 1– 3 392 
μg RNA using Roche Transcriptor cDNA Synth kit. Briefly, RNA was diluted in RNase-free water 393 
and mixed on ice with 1 μl oligo-dT primers (50pmol/μl), 2 μl random hexamers (600 pmol/μl), 4 μl 394 
Transcriptor RT Reaction Buffer (5x), 0.5 μl Protector RNase Inhibitor (40 U/μl), 2 μl 395 
Deoxynucleotide Mix (10 mM each), 0.5 μl Transcriptor Reverse Transcriptase and made up to 20 396 
μl with RNAase-free water. Reaction mixtures were incubated for 2 min at 25°C, 40 min at 42°C 397 
and 5 min at 95°C. Resultant cDNA was stored at -20°C.  398 
 qPCR was performed in an Mx3000P QPCR System (Stratagene) using Roche FS 399 
Universal SYBR Green MasterRox. Briefly, cDNA (equivalent to 6ng of starting RNA) was mixed 400 
with concentrated master mix (2x) and appropriate forward and reverse primers (20nM; Table S6) 401 
and made up to a final volume of 15 μl with RNase-free water. Technical replicates as well as no 402 
template and no RT controls were included in each run. Gene expression levels were normalized 403 
in all cases to Gapdh housekeeping control. Primer sequences used are as follows: 404 
 405 
Primer Sequence 
Human-ARC F: 5’-CTGAGCCACCTAGAGGAGTACT-3’. R: 5’-AACTCCACCCAGTTCTTCACGG-3’ 
Mouse-Arc F: 5’-GCTGGAAGAAGTCCATCAAGGC-3’. R: 5’-ACCTCTCCAGACGGTAGAAGAC-3’ 
Human-BDNF F: 5’-AGCTGAGCGTGTGTGACAGT-3’ . R: 5’-ATGGGATTGCACTTGGTCTC-3’ 
Mouse-Bdnf F: 5’-AAAGTCCCGGTATCCAAAGG-3’. R: 5’-CTTATGAATCGCCAGCCAAT-3’ 
Human-CCNH F: 5’-CGATGTCATTCTGCTGAGCTTGC-3’. R: 5’-TCTACCAGGTCGTCATCAGTCC-3’ 
Mouse-Ccnh F: 5’-ACTTGCCTGTCACAGTTACTGGA-3’. R: 5’-GAATGACACCGCTCCAGCTTCT-3’ 
Human-ETS2 F: 5’-CAACTCCTTTTCAGAGATCAGG-3’. R: 5’-TTTCATCAAGACCCCTACCG-3’ 
Mouse-Ets2 F: 5’-TCACGTAAAGGGAGATGTGTCG-3’. R: 5’-TGCTCTGTCTGTGCTTCTGG-3’ 
Human-FOS F: 5’-CTACCACTCACCCGCAGACT-3’. R: 5’-AGGTCCGTGCAGAAGTCCT-3’ 
Mouse-Fos F: 5’-CCATGATGTTCTCGGGTTTC-3’. R: 5’-TGGCACTAGAGACGGACAGA-3’ 
Human-FOSB F: 5’-GCCGGGAACGAAATAAACTA-3’. R: 5’-CACCAGCACAAACTCCAGAC-3’ 
Mouse-Fosb F: 5’-AGGGAGCTGACAGATCGACTT-3’. R: 5’-CTTCGTAGGGGATCTTGCAG-3’ 
Human-FOSL2 F: 5’-ACACCCTGTTTCCTCTCCG-3’. R: 5’-GATGGTGGGGATGAATGCAC-3’ 
Mouse-Fosl2 F: 5’-CGGGAACTTTGACACCTCGT-3’. R: 5’-AGGGATGTGAGCGTGGATAG-3’ 
Human-GAPDH F: 5’-CTTCACCACCATGGAGAAGGC-3’. R: 5’-GGCATGGACTGTGGTCATGAG-3’ 
Mouse-Gapdh F: 5’-GGGTGTGAACCACGAGAAAT-3’. R: 5’-CCTTCCACAATGCCAAAGTT-3’ 
Human-NPAS4 F: 5’-CCTGCATCTACACTCGCAAG-3’. R: 5’-CTCGCTCACACTCTCAGACA-3’ 
Mouse-Npas4 F: 5’-AGGGTTTGCTGATGAGTTGC-3’. R: 5’-CCCCTCCACTTCCATCTTC-3’ 
Human-PER1 F: 5’-TCAACTGCCTGGACAGCATCCT-3’. R: 5’-TCAGAGGCTGAGGAGGTGGTAT-3’ 
Mouse-Per1 F: 5’-GAAACCTCTGGCTGTTCCTACC-3’. R: 5’-AGGCTGAAGAGGCAGTGTAGGA-3’ 
Human-SIK1 F: 5’-CTCAGAGAGGGCAGAGGTGA-3’. R: 5’-ATGCATAAACGTCAGCAGCA-3’ 
Mouse-Sik1 F: 5’-GTGCCATCCAAACACCTCTG-3’. R: 5’-TGTCTGGAGAGTAAGCGGTA-3’ 
Human-SLC2A3 F: 5’-TGCCTTTGGCACTCTCAACCAG-3’. R: 5’-GCCATAGCTCTTCAGACCCAAG-3’ 
Mouse-Slc2a3 F: 5’-CCGCTTCTCATCTCCATTGTCC-3’. R: 5’-CCTGCTCCAATCGTGGCATAGA-3’ 
Human-PTDSS1 F: 5’- ATGTGATCACCTGGGAGAGG-3’. R: 5’- CCATTGCACAACAGGATGTC-3’ 
Mouse-Ptdss1 F: 5’- ACACAGTGCAAGCGTGTAGG-3’. R: 5’-AACCATGCCGTACAGACACA-3’ 
Human-ATP1B1 F: 5’-CCGCCAGGATTAACACAGAT-3’. R: 5’-TCCTCGTTCTTTCGGTTCAC-3’ 
Mouse-Atp1b1 F: 5’-CAGATTCCCCAGATCCAGAA-3’. R: 5’-CTGCACACCTTCCTCTCTCC-3’ 
Human-KCTD1 F: 5’-AGTCGGCCCAATATGTCAAG-3’. R: 5’-CCGATTCTGGATTCAGGGTA-3’ 
Mouse-Kctd1 F: 5’-AGTCGGCCCAATATGTCAAG -3’. R: 5’-TTCTGGATTCGGGGTATTTG -3’ 
Human-LMBRD2 F: 5’-TTGGGATAGCTGCTGCAAAT-3’. R: 5’-CTCCATGGCATCTTCCAAAT-3’ 
Mouse-Lmbrd2 F: 5’-GTGCGGCTTTAGGACTTGAG-3’. R: 5’-CAGCGGCAGTATGAAGACAA-3’ 
Human-TRAFD1 F: 5’-AAGGAGGGGAAGATTTTGGA-3’. R: 5’-GCCTGAGCACCTTACCAGAG-3’ 
Mouse-Trafd1 F: 5’-AGTCTGTGCCTGAGGCTGAT-3’. R: 5’-GAGAAGGGTTGCAGCTTGTC-3’ 
 406 
Statistical analysis, equipment and settings. Statistical testing of the RNA-seq data is described in 407 
that section. Other testing involved a 2-tailed paired Student's t-test., or a one- or two-way ANOVA 408 
followed by Sidak’s post-hoc test, as indicated in the legends. Correlation coefficients were 409 
calculated assuming a Gaussian distribution of the data. Throughout the manuscript, independent 410 
biological replicates are defined as independently performed experiments on material derived from 411 
different animals 412 
 413 
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 527 
Figure Legends 528 
Figure 1. Conservation and divergence in gene regulation in neurons of human and mouse 529 
origin. All data can be found in Supplemental Table 1. A,B) Analysis of gene expression changes 530 
induced by KCl/FPL in Hum-ESCCORT-neurons (A) and DIV10 Mus-PRIMCORT-neurons (B). 531 
Normalised RNA-seq read density (FPKM) mapping to each gene in RNA extracted from control vs. 532 
KCl/FPL-treated neurons is shown (n=3 independent biological replicates). Genes whose 533 
expression was significantly altered by KCl/FPL treatment (Benjamini-Hochberg-adjusted p-value 534 
<0.05, calculated within DESeq2) are highlighted in red. C) Cohort of human:mouse orthologous 535 
pairs where both are strongly (>5 fold) and significantly (Benjamini-Hochberg-adjusted P-value 536 
<0.05) induced in Hum-ESCCORT-neurons and DIV10 Mus-PRIMCORT-neurons respectively. D) 537 
Correlation of KCl/FPL-induced fold-change in 11,302 ortholog pairs in DIV10 Mus-PRIMCORT-538 
neurons vs. DIV10-Hum-ESCCORT-neurons. E) Correlation of KCl/FPL-induced fold-change in the 539 
same 11,302 genes as in (D) in DIV10 vs. DIV4 Mus-PRIMCORT-neurons. 540 
 541 
Figure 2. Stem cell origin does not substantially impact on activity-dependent gene 542 
responsiveness. A) Example immunofluorescence pictures of Mus-ESCCORT-neurons stained for 543 
neuronal markers Tuj1 (upper) and Reelin (lower). Note also absence of Nestin staining (upper), a 544 
marker of undifferentiated neural precursor cells. Scale=20 µm.  B) Example trace of a burst of 545 
action potentials (APs) induced in Mus-ESCCORT-neurons by current injection (see methods). C) 546 
Example trace illustrating spontaneous TTX-sensitive AP firing. D) Example trace illustrating 547 
spontaneous TTX-sensitive EPSCs, as well as TTX-insensitive, CNQX-sensitive miniature EPSCs 548 
(also see inset; scale bar: 20 pA, 5 ms). Activity returned upon wash out of TTX and CNQX (not 549 
shown). E,F) Correlation of KCl/FPL-induced fold-change in the same 11,302 genes as in Fig. 1d,e 550 
in Mus-ESCCORT-neurons vs. DIV10 (E) or DIV4 (F) Mus-PRIMCORT-neurons. G) Correlation of 551 
KCl/FPL-induced fold-change in 11,302 ortholog pairs in Mus-ESCCORT-neurons vs. Hum-ESCCORT-552 
neurons. H) A connection map generated in Cytoscape 42 illustrating the relative determination 553 
coefficients (R2) between the fold-inductions of the 11,302 genes studied in each of the three 554 
biological replicates of the experiments performed in each of the four different neuronal 555 
preparations. The thickness of the connecting line and the attractive force of the connecting nodes 556 
are both directly proportional to R2, against a background of constant inter-node repulsion. Note 557 
that all mouse neurons of differing developmental stage and origin (primary vs. ES cell) cluster 558 
strongly together, with the Hum-ESCCORT-neuronal replicates clustering away from them. I) A 559 
connection map generated as for (H) but illustrating the relative determination coefficients (R2) 560 
between the basal expression levels (FPKM) of the 11,302 genes studied in each of the three 561 
biological replicates of the experiments performed in each of the four different neuronal 562 
preparations. 563 
 564 
Fig. 3. DNA sequence is a contributing factor to species-dependent gene responsiveness to 565 
neuronal activity. A) Analysis of gene expression changes induced by KCl/FPL in mouse Tc1 566 
neurons. Mouse genes are shown in grey, human chromosome-21 (Hsa-21) genes in red. B) The 567 
graph concerns 72 orthologous pairs whose human ortholog is on Hsa-21 and carried by the Tc1 568 
mouse strain, and which meets expression cut-off (100 reads). For each pair, the differential 569 
responsiveness index (DRI) was calculated from the species-separated Tc1 neuron RNA-seq 570 
data(see text), and plotted against the DRI calculated from separate neuronal preparations (Hum-571 
ESCCORT-neurons vs. DIV10 Mus-PRIMCORT-neurons, as was done in Figure 1-figure supplement 572 
1e). C) KCl/FPL-induced fold induction of the human (red) and mouse (blue) orthologs of Hsa-21 573 
gene ETS2, analysed side-by-side in Tc1 neurons. *P=0.035. unpaired t-test; # indicates P=0.0464, 574 
0.0026 (left to right) vs. unstimulated control (4h, n=7; 24h, n=3). D) Kinetics of KCl/FPL-induced 575 
ETS2 induction in Hum-ESCCORT-neurons vs. DIV10 Mus-PRIMCORT-neurons. *P=0.0017, 0.004 576 
(left to right), unpaired 1-way ANOVA vs. control (Hum-ESCCORT-neurons: n=3 (2h, 8h), n=6 (4h), 577 
P=; DIV10 Mus-PRIMCORT-neurons: n=4, P. E) The indicated firefly luciferase reportersbased on 578 
human (Hsa) or mouse (Mmu) ETS2 promoters (See (Right) for schematic) plus a pTK-renilla 579 
control were transfected into mouse cortical neurons, treated ± KCl/FPL after which firefly:renilla 580 
luciferase ratio was measured, and fold-induction calculated. For comparing the effect of TAM67, a 581 
control vector (encoding β-globin) was used. *P=0.0015, 0.0015, 0.0015, 2-tailed paired t-test 582 
(n=3). F) Kinetics of gene regulation of 6 human:mouse ortholog pairs that show quantitative 583 
differences in activity-dependent regulation in Hum-ESCCORT-neurons vs. all mouse neuronal 584 
preparations from prior RNA-seq analyses. Analysis was performed in Hum-ESCCORT-neurons vs. 585 
DIV10 Mus-PRIMCORT-neurons (n=3,4 respectively). At the timepoints studied, three of these pairs 586 
exhibit quantitatively higher induction in human neurons, and three stronger repression in human 587 
neurons. *P=<0.0001, 0.0004, 0.0005, <0.0001, <0.0001, 0.0073 (top to bottom, 2-way ANOVA, P-588 
value corresponds to the main species effect).  589 
 590 
 591 
 592 
Figure Supplement Legends 593 
Figure 1-figure supplement 1. A) Example fluo-3 Ca2+ imaging trace of KCL/FPL-treated Hum-594 
ESCCORT-neurons. B) qPCR analysis of the fold induction of the indicated genes in Hum-ESCCORT-595 
neurons after 4h of KCl/FPL treatment. *P=0.0001, 0.0013, 6E-05, 0.0005, 0.0086, 0.0010, 2-tailed 596 
t-test (n=3). C,D) A comparison of the magnitude of gene induction of a selection of human (C) and 597 
mouse (D) genes, as assayed by RNA-seq and by qRT-PCR. In both cases identical sets of 3 598 
independent replicates were assayed and the mean calculated. E) For the 11,302 orthologous 599 
pairs, the "differential regulation index" (DRI) was calculated, defined as the fold-change (Hum-600 
ESCCORT-neurons) divided by the fold-change (DIV10 Mus-PRIMCORT-neurons). The distribution of 601 
the log2 of the DRIs is shown. F) As for (E) except the DRI was calculated for DIV4 vs. DIV10 Mus-602 
PRIMCORT-neurons. G) Correlation of KCl/FPL-induced fold-change in 11,302 ortholog pairs in 603 
DIV4 Mus-PRIMCORT-neurons vs. Hum-ESCCORT-neurons. 604 
 605 
Figure 2-figure supplement 1. A) Normalised RNA-seq read density (FPKM) mapping to each 606 
gene in RNA extracted from control vs. KCl/FPL-treated Mus-ESCCORT-neurons is shown (n=3 607 
independent biological replicates). Genes whose expression was significantly altered by KCl/FPL 608 
treatment (Benjamini-Hochberg-adjusted p-value <0.05, calculated within DESeq2) are highlighted 609 
in red. B-D) Correlation of basal gene expression (Log2(FPKM)) across 11,302 ortholog pairs in 610 
Hum-ESCCORT-neurons vs. DIV4 Mus-PRIMCORT-neurons (B), DIV4 Mus-PRIMCORT-neurons (C) 611 
and Mus-ESCCORT-neurons (D). E) For each of the 11,302 orthologous pairs, the Log2(DRI) Hum-612 
ESCCORT-vs. DIV10 Mus-PRIMCORT-neurons (i.e. DRIs from Figure 1-figure supplement 1e)  were 613 
plotted against the Log2(DBEI), where DBI (differential basal expression index) is the ratio of basal 614 
expression in Hum-ESCCORT-vs. DIV10 Mus-PRIMCORT-neurons. 615 
 616 
Figure 3-figure supplement 1. A) Correlation of KCl/FPL-induced fold-change in the same 11,302 617 
mouse genes analysed in Figs 1 and 2,in DIV10 Mus-ESCCORT-neurons from wild-type vs. Tc1 618 
primary cortical neurons, showing the expected high correlation.  619 
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Figure 1-figure supplement 1. 
 
Figure 1-figure supplement 1. A) Example fluo-3 Ca2+ imaging trace of KCL/FPL-treated Hum-
ESCCORT-neurons. B) qPCR analysis of the fold induction of the indicated genes in Hum-ESCCORT-
neurons after 4h of KCl/FPL treatment. *P=0.0001, 0.0013, 6E-05, 0.0005, 0.0086, 0.0010, 2-tailed 
t-test (n=3). C,D) A comparison of the magnitude of gene induction of a selection of human (C) and 
mouse (D) genes, as assayed by RNA-seq and by qRT-PCR. In both cases identical sets of 3 
independent replicates were assayed and the mean calculated. E) For the 11,302 orthologous 
pairs, the "differential regulation index" (DRI) was calculated, defined as the fold-change (Hum-
ESCCORT-neurons) divided by the fold-change (DIV10 Mus-PRIMCORT-neurons). The distribution of 
the log2 of the DRIs is shown. F) As for (E) except the DRI was calculated for DIV4 vs. DIV10 Mus-
PRIMCORT-neurons. G) Correlation of KCl/FPL-induced fold-change in 11,302 ortholog pairs in 
DIV4 Mus-PRIMCORT-neurons vs. Hum-ESCCORT-neurons. 
 
Figure 2-figure supplement 1. 
 
 
Figure 2-figure supplement 1. A) Normalised RNA-seq read density (FPKM) mapping to each 
gene in RNA extracted from control vs. KCl/FPL-treated Mus-ESCCORT-neurons is shown (n=3 
independent biological replicates). Genes whose expression was significantly altered by KCl/FPL 
treatment (Benjamini-Hochberg-adjusted p-value <0.05, calculated within DESeq2) are highlighted 
in red. B-D) Correlation of basal gene expression (Log2(FPKM)) across 11,302 ortholog pairs in 
Hum-ESCCORT-neurons vs. DIV4 Mus-PRIMCORT-neurons (B), DIV4 Mus-PRIMCORT-neurons (C) 
and Mus-ESCCORT-neurons (D). E) For each of the 11,302 orthologous pairs, the Log2(DRI) Hum-
ESCCORT-vs. DIV10 Mus-PRIMCORT-neurons (i.e. DRIs from Figure 1-figure supplement 1e)  were 
plotted against the Log2(DBEI), where DBI (differential basal expression index) is the ratio of basal 
expression in Hum-ESCCORT-vs. DIV10 Mus-PRIMCORT-neurons. 
  
 
 
Figure 3-figure supplement 1. 
 
Figure 3-figure supplement 1. A) Correlation of KCl/FPL-induced fold-change in the same 11,302 
mouse genes analysed in Figs 1 and 2,in DIV10 Mus-ESCCORT-neurons from wild-type vs. Tc1 
primary cortical neurons, showing the expected high correlation.  
